Gene therapy for arthritis: principles and clinical practice.
Kang
R
R
Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, PA 15261, USA.
Ghivizzani
S C
SC
Herndon
J H
JH
Robbins
P D
PD
Evans
C H
CH
D000256:Adenoviridae; D000818:Animals; D015703:Antigens, CD / Q000096:biosynthesis / Q000235:genetics; D001169:Arthritis, Experimental / Q000235:genetics / Q000276:immunology / Q000628:therapy; D001172:Arthritis, Rheumatoid / Q000235:genetics / Q000276:immunology / Q000628:therapy*; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D005822:Genetic Vectors; D006801:Humans; D007249:Inflammation; D053590:Interleukin 1 Receptor Antagonist Protein; D051379:Mice; D016513:Mice, SCID; D010003:Osteoarthritis / Q000235:genetics / Q000276:immunology / Q000628:therapy*; D017472:Receptors, Interleukin-1 / Q000037:antagonists & inhibitors; D018124:Receptors, Tumor Necrosis Factor / Q000096:biosynthesis / Q000235:genetics; D047889:Receptors, Tumor Necrosis Factor, Type II; D012795:Sialoglycoproteins / Q000096:biosynthesis / Q000235:genetics
D015703:Antigens, CD; C507763:IL1RN protein, human; C507764:Il1rn protein, mouse; D053590:Interleukin 1 Receptor Antagonist Protein; D017472:Receptors, Interleukin-1; D018124:Receptors, Tumor Necrosis Factor; D047889:Receptors, Tumor Necrosis Factor, Type II; D012795:Sialoglycoproteins